LITS
Lite Strategy, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.16
+0.87%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$3.12
- Revenue estimate
- $5.4M
Latest reported
- Last report date
- Sep 28, 2026
- EPS actual
- -$0.38
- EPS estimate
- -$3.12
- Revenue actual
- —
- Revenue estimate
- $5.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +69.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 28, 2026 | -$3.12 | -$0.38 | Beat 87.80% | — |
| May 13, 2026 | -$3.12 | -$0.66 | Beat 78.82% | — |
| Feb 17, 2026 | — | -$0.82 | — | — |
| Nov 14, 2025 | — | -$0.12 | — | — |
| Jun 30, 2025 | — | -$0.40 | — | — |
| Dec 31, 2024 | -$2.20 | -$0.40 | Beat 81.74% | — |
| Sep 30, 2024 | -$1.70 | -$1.20 | Beat 29.31% | — |
| Jun 30, 2024 | — | -$2.76 | — | — |
| Feb 13, 2024 | -$1.41 | -$1.66 | Miss -17.45% | — |
| Nov 9, 2023 | -$1.79 | $8.46 | Beat 571.31% | $65.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026